Inventor
COURT JOHN J
US29 patents
⚠️ This page may combine multiple inventors who share the name “COURT JOHN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
17 patentsUS8829007B2Sep 9, 2014
Inhibitors of influenza viruses replication
VERTEX PHARMA28 citations95
US7378422B2May 27, 2008
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA39 citations95
US9808459B2Nov 7, 2017
Inhibitors of influenza viruses replication
VERTEX PHARMA11 citations92
US9518056B2Dec 13, 2016
Inhibitors of influenza viruses replication
VERTEX PHARMA16 citations92
US9359380B2Jun 7, 2016
DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9345708B2May 24, 2016
Inhibitors of influenza viruses replication
VERTEX PHARMA21 citations92
US9340557B2May 17, 2016
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA19 citations92
US10973830B2Apr 13, 2021
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10786512B2Sep 29, 2020
DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10258627B2Apr 16, 2019
DNA-PK inhibitors
VERTEX PHARMA4 citations84
US10039762B2Aug 7, 2018
Inhibitors of influenza viruses replication
VERTEX PHARMA7 citations84
US9987284B2Jun 5, 2018
Substituted benzooxadiazole DNA-PK inhibitors
VERTEX PHARMA5 citations84
US7683033B2Mar 23, 2010
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA7 citations71
US12251387B2Mar 18, 2025
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11813267B2Nov 14, 2023
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US7745444B2Jun 29, 2010
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
VERTEX PHARMA3 citations61
US10874673B2Dec 29, 2020
Inhibitors of influenza viruses replication
VERTEX PHARMA0 citations52
STERLING WINTHROP INC
10 patentsUS5494925AFeb 27, 1996
2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
STERLING WINTHROP INC87 citations96
US5488062AJan 30, 1996
2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
STERLING WINTHROP INC23 citations92
US5187173AFeb 16, 1993
2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
STERLING WINTHROP INC7 citations74
US5250696AOct 5, 1993
2-saccharinylmethyl aryl carboxylate
STERLING WINTHROP INC10 citations73
US5128339AJul 7, 1992
Proteolytic enzyme inhibition method
STERLING WINTHROP INC17 citations73
US5563163AOct 8, 1996
2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
STERLING WINTHROP INC2 citations63
US5541168AJul 30, 1996
Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
STERLING WINTHROP INC5 citations63
US5296496AMar 22, 1994
2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
STERLING WINTHROP INC7 citations63
US5597841AJan 28, 1997
2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
STERLING WINTHROP INC3 citations62
US5512589AApr 30, 1996
2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
STERLING WINTHROP INC5 citations62